Browse All

Current Filters

CLEAR FILTER x

TITLE

Phase 3, Open-Label, Safety Extension Study of Oral Edaravone (Radicava ORS®) Administered Over 96 Weeks in Patients with ALS (MT-1186-A03)

Author:Genge, Angela   Pattee, Gary   Sobue, Gen   Aoki, Masashi   Yoshino, Hiide   Couratier, Philippe   Lunetta, Christian   Petri, Susanne   Selness, Daniel   Todorovic, Vesna   Hirai, Manabu   Salah, Alejandro   Apple, Stephen   Wamil, Art   Kalin, Alexander   Jackson, Carlayne A.   

Session Name:S27: General Neurology 2  

Topic:General Neurology  

Program Number:S27.007  

Author Institution:Montreal Neurological Institute and Hospital, Montreal, QC, Canada  University of Nebraska Medical Center, Lincoln, NE  Nagoya University Graduate School of Medicine, Aichi Medical University, Nagoya, Aichi, Japan  Tohoku University School of Medicine, Sendai, Miyagi, Japan  Neurology Clinic, Chiba, Japan  CRMR SLA Service de Neurologie, CHU de Limoges, Limoges, France  Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation Unit of Milano , Milan, Italy  Hannover Medical School, Hannover, Germany  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  Mitsubishi Tanabe Pharma Europe Ltd., London, United Kingdom  Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan  University of Texas Health Science Center at San Antonio, San Antonio, TX  

Long-term Function and Survival of Radicava ORS® (Oral Edaravone)-Treated Patients With ALS vs Propensity Score–Matched PRO-ACT Historical Controls

Author:Takahashi, Fumihiro   Genge, Angela   Yoneoka, Takatomo   Hirai, Manabu   Selness, Daniel   Todorovic, Vesna   Wamil, Art   Sasson, Nissim   Apple, Stephen   Yoshiteru, Ushirogawa   

Session Name:P8: General Neurology: Motor Neuron Disease 1  

Topic:General Neurology  

Program Number:P8.003  

Author Institution:Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  Montreal Neurological Institute and Hospital, Montreal, QC, Canada  Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan  Mitsubishi Tanabe Pharma Europe, Ltd, London, United Kingdom  NStat Solutions, Biostatistical Services, Rehovot, Israel  

Application of a Clinical Algorithm on Real-World Electronic Medical Record Data to Assist With Earlier Detection of Amyotrophic Lateral Sclerosis

Author:Fiander, Amanda   Ghavanini, Amer   Pham, Dung   Kainth, Pinay   Genge, Angela   

Session Name:P8: General Neurology: Motor Neuron Disease 1  

Topic:General Neurology  

Program Number:P8.010  

Author Institution:Maritime Neurology, Halifax, NS, Canada  Montreal Neurological Institute and Hospital, Montreal, QC, Canada  

Extension Study MT-1186-A04 Evaluating Oral Edaravone (Radicava ORS®) Continued Efficacy and Safety up to an Additional 48 Weeks in Patients With ALS

Author:Genge, Angela   Rothstein, Jeffrey   De Silva, Shari   Zinman, Lorne   Chum, Marvin   Chio, Adriano   Sobue, Gen   Doyu, Manabu   Selness, Daniel   Todorovic, Vesna   Sasson, Nissim   Takahashi, Fumihiro   Cecic, Michelle   Wamil, Art   Apple, Stephen   

Session Name:P9: General Neurology: Motor Neuron Disease 2  

Topic:General Neurology  

Program Number:P9.007  

Author Institution:Montreal Neurological Institute and Hospital, Montreal, QC, Canada  Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD  Woodland Research Northwest, Rogers, AR  Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada  McMaster University Health Sciences Centre, Hamilton, ON, Canada  Università degli Studi di Torino, Centro Regionale Esperto per la Sclerosi Laterale Amiotrofica (CRESLA), Torino, Italy  Nagoya University Graduate School of Medicine, Aichi Medical University, Nagoya, Japan  Department of Neurology, Aichi Medical University, Nagakute, Japan  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  Mitsubishi Tanabe Pharma Europe, Ltd., London, United Kingdom  NStat Solutions, Biostatistical Services, Rehovot, Israel